Skip to main content
SpringerLink
Log in

Vaccinia Virus as an Expression Vector

  • Protocol
Book cover Practical Molecular Virology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 8))

  • 967 Accesses

Abstract

Vaccinia virus (Vv) is a member of the genus Orthopoxvirus, one of seven genera included in the family Poxviridae. Most of these viruses infect vertebrates (Orthopoxvirus, Avipoxvirus, Capripoxvirus, Leporipoxvirus, Suipoxvirus, and Parapoxvirus), but one genus, Entomopoxvirus, infects insects. It is interesting to note that the Fibroma and Mixoma viruses of the leporipoxvirus genus cause tumors in their hosts (rabbits), these being the only tumorigenic viruses in the family (1,2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Muller, G. and Williamson, J. D. (1987) Poxviridae, in Animal Virus Structure (Nermut, M V and Steven, A C, eds.), Elsevier, Amsterdam, pp. 421–433.

    Chapter  Google Scholar 

  2. Ginsberg, H. S. (1990) Poxviruses, in Microbiology 4th Ed (Davis, B. D., Dulbecco, R., Eisen, H. N, and Ginsberg, H. S., eds.), Lippincott, Philadelphia, PA, pp. 947–959.

    Google Scholar 

  3. Panicah, D. and Paoletti, E. (1982) Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious Vaccinia virus. Proc. Natl Acad. Sci. USA 79, 4927–4931.

    Article  Google Scholar 

  4. Mackett, M., Smith, G. L., and Moss, B. (1982) Vaccinia virus: A selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79, 7415–7419.

    Article  PubMed  CAS  Google Scholar 

  5. Piccini, A and Paoletti, E. (1988) Vaccinia Virus, vector, vaccine. Adv. Virus Res. 34, 43–64.

    Article  PubMed  CAS  Google Scholar 

  6. Wachsman, M., Aurelian, L, Smith, C. C., Lipinskas, B.R, Perkus, M. E., and Paoletti, E. (1987) Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with Vaccinia virus recombinants expressing HSV glycoprotein D. J. Infect. Dis. 155, 1188–1197.

    PubMed  CAS  Google Scholar 

  7. King, A. M. Q., Stott, E J., Langer, S. J., Young, K. K.-Y, Ball, L. A., and Wertz, G. W. (1987) Recombinant Vaccinia viruses carrying the N gene of human respiratory syncitial virus. Studies of gene expression in cell culture and immune response in mice. J. Virol 61, 2885–2890.

    PubMed  CAS  Google Scholar 

  8. Spriggs, M. K, Collins, P L., Tierney, E., London, W. T., and Murphy, B R. (1988) Immunization with Vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects Patas monkeys against PIV3 infection. J. Virol. 62, 1293–1296.

    PubMed  CAS  Google Scholar 

  9. Pensiero, M. N., Jennings, G. B, Schmaljohn, C. S., and Hay, J. (1988) Expression of the Hantan virus M genome segment by using a Vaccinia virus recombinant. J. Virol. 62, 696–702.

    PubMed  CAS  Google Scholar 

  10. Karacostas, V., Nagashima, K., Gonda, M. A., and Moss, M. (1989) Human immunodeficiency virus-like particles produced by a Vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86, 8964–8967.

    Article  PubMed  CAS  Google Scholar 

  11. Franke, C. A. and Hruby, D. E. (1987) Association of nonviral proteins with recombinant vaccinia viruses. Arch, Virol. 94, 347–351.

    Article  CAS  Google Scholar 

  12. Huang, C, Samsonoff, W. A., and Grzelechi, A. (1988) Vaccinia virus recombinants expressing an 11-kilodalton-β galactosidase fusion protein incorporate active β galactosidase in virus particles. J. Virol 62, 3855–3861

    PubMed  CAS  Google Scholar 

  13. Benninck, J. R, Yewdell, J. W., Smith, G. L., Moller, C, and Moss, B. (1984) Recombinant Vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells Nature 311, 578,579.

    Article  Google Scholar 

  14. Yewdell, J. W., Benninck, J. R., Smith, G. L., and Moss, B. (1988) Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 82, 1785–1789

    Article  Google Scholar 

  15. Jonjic, S, del Val, M., Keil, G. M., Reddehase, M. J., and Koszinowski, U. H. (1988) A nonstructural viral protein expressed by a recombinant Vaccinia virus protects against lethal cytomegalovirus infection. J. Virol. 62, 1653–1658.

    PubMed  CAS  Google Scholar 

  16. McLaughlin-Taylor, E, Willey, D. E., Cantin, E. M., Eberle, R., Moss, B., and Openshaw, H (1988) A recombinant Vaccinia virus expressing Herpes simplex virus type I glycoprotein B induces cytotoxic T lymphocytes in mice. J. Gen. Virol. 69, 1731–1734

    Article  PubMed  CAS  Google Scholar 

  17. Flexner, C, Broiles, S. S., Earl, P., Chakrabarti, S., and Moss, B. (1988) Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant Vaccinia viruses. Virology 166, 339–349.

    Article  PubMed  CAS  Google Scholar 

  18. Edwards, R. H., Selby, M. J., Mobley, W. C, Weinrich, S. L., Hruby, D. E., and Rutter, W. J. (1988) Processing and secretion of nerve growth factor: Expression in mammalian cells with a Vaccinia virus vector. Mol. Cell. Biol. 8, 2456–2464.

    PubMed  CAS  Google Scholar 

  19. de la Salle, H., Altenburger, W., Elkaim, R., Dott, K, Dieterle, A., Drilhen, R., Cazenave, J.-P., Tolstoshev, P., and Lecocq, J.-P. (1985) Acitive gammacarboxyleted human factor IX expressed using recombinant DNA techniques. Nature 316, 268–270.

    Article  PubMed  Google Scholar 

  20. Moss, B. (1985) Replication of poxviruses, in Virology (Fields, B. N., Chanock, R. M., and Roizman, B., eds.), Raven, New York, pp. 685–703.

    Google Scholar 

  21. Wittek, R., Menna, A., Schumperli, D., Stoffel, S, Muller, H. K., and Wiler, R. (1977) Hind III and Sst I restriction sites mapped on rabbit poxvirus and Vaccinia virus DNA. J. Virol 23, 669–678.

    PubMed  CAS  Google Scholar 

  22. Geshelin, P. and Berns, K. I. (1974) Characterization and localization of the naturally occurying crosslinks in Vaccinia virus DNA. J. Mol Biol 88, 785–796

    Article  PubMed  CAS  Google Scholar 

  23. Baroudy, B. M., Venkatesan, S., and Moss, B. (1982) Incomplete base-paired flip-flop terminal loops link the two DNA strands of the Vaccinia virus genome into an uninterrupted polynucleotide chain. Cell 28, 315–324.

    Article  PubMed  CAS  Google Scholar 

  24. Baroudy, B. M., Venkatesan, S., and Moss, B. (1983) Structure and replication of Vaccinia virus telomeres, in Symposium on Quantitative Biology, vol. 47, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 723–729.

    Google Scholar 

  25. Moyer, R. W and Graves, R. L. (1981) The mechanism of cytoplasmic orthopoxvirus DNA replication. Cell 27, 391–401.

    Article  PubMed  CAS  Google Scholar 

  26. Garon, C. F., Barbosa, E., and Moss, B. (1978) Visualization of an inverted repetition in Vaccinia virus DNA. Proc. Natl. Acad. Sci. USA 75, 4863–4867.

    Article  PubMed  CAS  Google Scholar 

  27. Wittek, R. and Moss, B. (1980) Tandem repeats within the inverted terminal repetitions of Vaccinia virus DNA. Cell, 21 277–284.

    Article  PubMed  CAS  Google Scholar 

  28. Tomley, F. M. and Cooper, R. J. (1984) The DNA polymerase activity of Vaccinia virus “Virosomes”: Solubilization and properties. J. Gen. Virol 65, 825–829.

    Article  PubMed  CAS  Google Scholar 

  29. Munyon, W., Paoletti, E., and Grace, J. T., Jr. (1967) RNA polymerase activity in purified infectious Vaccinia virus. Proc. Natl. Acad. Sci. USA 58, 2280–2287.

    Article  PubMed  CAS  Google Scholar 

  30. Baroudy, B. M. and Moss, B. (1980) Purification and characterization of a DNA dependent RNA polymerase from Vaccinia virus. J. Biol. Chem. 255, 4372–4380.

    PubMed  CAS  Google Scholar 

  31. Monroy, G., Spencer, H., and Hurwitz J. (1978) Purification of mRNA guanylyl transferase from Vaccinia virions. J. Biol. Chem. 253, 4481–4489.

    PubMed  CAS  Google Scholar 

  32. Barbosa, E. and Moss, B. (1977) mRNA (nucleoside-2′-)-methyl transferase from Vaccinia virus. J. Biol. Chem. 253, 7692–7697.

    Google Scholar 

  33. Moss, B., Rosenblum, E. N., and Gershowitz, A. (1975) Characterization of polyadenylate polymerase from Vaccinia vinons. J. Biol Chem. 250, 4722–4729.

    PubMed  CAS  Google Scholar 

  34. Traktman, P., Sheidar, P., Condit, R. C, and Roberts, B. E. (1984) Transcriptional mapping of the DNA polymerase gene of Vaccinia virus. J. Virol. 49, 125–131.

    PubMed  CAS  Google Scholar 

  35. Earl, P. L., Jones, E. V., and Moss, B. (1986) Homology between DNA polymerases of poxviruses, herpesviruses and adenoviruses: Nucleotide sequence of the Vaccinia virus DNA polymerase gene. Proc. Natl. Acad. Sci. USA 83, 3659–3663.

    Article  PubMed  CAS  Google Scholar 

  36. Weir, J. P., Bajszar, G., and Moss, B. (1982) Mapping of the Vaccinia virus Thymidine kinase gene by marker rescue and cell-free translation of selected mRNA Proc. Natl. Acad. Sci. USA 79, 1210–1214.

    Article  PubMed  CAS  Google Scholar 

  37. Weir, J. P. and Moss, B. (1983) Nucleotide sequence of the Vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations. J. Virol. 46, 530–537.

    PubMed  CAS  Google Scholar 

  38. Hruby, D. E., Maki, R. A., Miller, D. B., and Ball, L. A. (1983) Fine structure analysis and nuleotide sequence of the Vaccinia virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 80, 3411–3415.

    Article  PubMed  CAS  Google Scholar 

  39. Smith, G. L., deCarlos, A., and San Chan, Y. (1989) Vaccinia virus encodes a thymidilate kinase gene: Sequence and transcriptional mapping. Nucleic Acids Res. 17, 7581–7590.

    Article  PubMed  CAS  Google Scholar 

  40. Bertholet, C, Van Heir, E., ten Heggeler-Bordier, B., and Wittek, R. (1987) Vaccinia virus produces late mRNA by discontinuous synthesis. Cell 50, 153–162.

    Article  PubMed  CAS  Google Scholar 

  41. Schwer, B. and Stunnenberg, H. G. (1988) Vaccinia virus late transcripts generated in vitro a poly(A) head. EMBO J. 7, 1183–1190.

    PubMed  CAS  Google Scholar 

  42. Wittek, R., Richner, B., and Hiller, G. (1984) Mapping of the genes coding for the two major Vaccinia virus core polypeptides. Nucleic Acids Res. 12, 4835–4847.

    Article  PubMed  CAS  Google Scholar 

  43. De Filippes, F. M. (1982) Retriction enzyme mapping of Vaccinia virus DNA. J. Virol. 43, 136–149.

    Google Scholar 

  44. Moss, B., Winters, E., and Cooper, J. A. (1981) Deletion of a 9000 base-pair segment of the Vaccinia virus genome that encodes nonessential polypepotides. J. Virol. 40, 387–395.

    PubMed  CAS  Google Scholar 

  45. Weir, J. P. and Moss, B. (1987) Determination of the promoter region of an early Vaccinia virus gene encoding Thymidine kinase. Virology 158, 206–210.

    Article  PubMed  CAS  Google Scholar 

  46. Davison, A. J. and Moss, B. (1990) Structure of Vaccinia virus early promoters. J. Mol. Biol. 210, 749–769.

    Article  Google Scholar 

  47. Davison, A.J. and Moss, B. (1990) Structure of Vaccinia virus late promoters.J. Mol. Biol. 210, 771–784.

    Google Scholar 

  48. Pellicer, A. and Esteban, M. (1982) Gene transfer, stability, and biochemical properties of animal cells transformed with Vaccinia DNA. Virology 122, 363–380.

    Article  PubMed  CAS  Google Scholar 

  49. Venkatesan, S. and Moss, B. (1981) In vitro transcription of the inverted terminal repetition of the Vaccinia virus genome: Correspondence of initiation and cap sites J. Vtrol. 37, 738–747.

    CAS  Google Scholar 

  50. Cochran, M.A., Puckett, C., and Moss, B. (1985) In Vitro mutagenesis of the promoter region for a Vaccinia virus gene. Evidence for tandem early and late regulatory signals. J. Virol. 54, 30–37.

    PubMed  CAS  Google Scholar 

  51. Bertholet, C, Drillien, R., and Wittek, R. (1985) One hundred base pairs 5′ flanking sequence of a Vaccinia virus late gene are sufficient to temporally regulate transcription. Proc. Natl. Acad. Sci. USA 82, 2096–2100.

    Article  PubMed  CAS  Google Scholar 

  52. Bolivar, F., Rodriguez, R. L., Greene, P.J., Betlach, M. C, Meyneker H. L., and Boyer, H. W. (1977) Construction and characterization of new cloning vehicles. II: A multipurpose cloning system. Gene 2, 95–113.

    Article  PubMed  CAS  Google Scholar 

  53. Mackett, M., Smith, G. I., and Moss, B. (1984) General method for production and selection of infectious Vaccinia virus recombinants expressing foreign genes. J. Virol. 49, 857–864.

    PubMed  CAS  Google Scholar 

  54. Vieira, J. and Messing, J. (1982) The pUC plasmids, an M13 mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19, 259–268.

    Article  PubMed  CAS  Google Scholar 

  55. Boyle, D. B., Coupar, B. E. H., and Both, G. W. (1985) Multiple-cloning-site for the rapid construction of recombinant poxviruses. Gene 35, 169–177.

    Article  PubMed  CAS  Google Scholar 

  56. Chakrabarti, S., Brechling, K, and Moss, B. (1985) Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403–3409.

    PubMed  CAS  Google Scholar 

  57. Wilson, E. M., Hodges, W. M., and Hruby, D. E. (1986) Construction of recombinant Vaccinia virus strains using single-stranded DNA insertion vectors. Gene 49,207–213.

    Article  PubMed  CAS  Google Scholar 

  58. Moss, B., Smith, G. L., and Mackett, M. (1983) Use of Vaccinia virus as an infectious molecular cloning and expression vector, in Gene Amplification and Analysts (Papas, T. K., Rosenberg, M. and Chirikjian, J. G., eds.), Elsevier, New York, pp. 201–213.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Nacional de Biotechnologia, Madrid, Spain

    Antonio Talavera

  2. Centro de Biologia Molecular (CSIS-UAM), Madrid, Spain

    Javier M. Rodriguez

Authors
  1. Antonio Talavera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier M. Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chester Beatty Laboratories, Institute of Cancer Research, London, UK

    Mary K. L. Collins

Rights and permissions

Reprints and permissions

Copyright information

© 1991 The Humana Press Inc., Clifton, NJ

About this protocol

Cite this protocol

Talavera, A., Rodriguez, J.M. (1991). Vaccinia Virus as an Expression Vector. In: Collins, M.K.L. (eds) Practical Molecular Virology. Methods in Molecular Biology, vol 8. Humana Press. https://doi.org/10.1385/0-89603-191-8:219

Download citation

  • DOI: https://doi.org/10.1385/0-89603-191-8:219

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-191-3

  • Online ISBN: 978-1-59259-495-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation